Click here to view the CareFirst BCBS Blue Cross Blue Shield Medical Policy Updates »…
BCBS Kansas City Medical Policy Updates – July 2021
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
July 2021 BCBS Kansas City Medical Policy Updates:
- Actigraphy
- Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
- Allergy Testing and Allergy Immunotherapy
- Allograft Injection for Degenerative Disc Disease
- Alzheimer’s Disease Step Therapy Program
- Automated Point-of-Care Nerve Conduction Tests
- Ayvakit (avapritinib)
- Biofeedback as a Treatment of Chronic Pain
- Biofeedback as a Treatment of Fecal Incontinence or Constipation
- Biofeedback as a Treatment of Headache
- C1 Esterase Inhibitors (Cinryze, Berinert, Haegarda, Ruconest)
- Chimeric Antigen Receptor Therapy for Multiple Myeloma
- Chromoendoscopy as an Adjunct to Colonoscopy
- Computer-Assisted Navigation for Orthopedic Procedure
- Diagnosis and Treatment of Sacroiliac Joint Pain
- Drug Infusion Site of Care Policy
- Dynamic Posturography
- Elmiron (pentosan polysulfate sodium)
- Enhertu (fam-trastuzumab deruxtecan-nxki)
- Fecal Microbiota Transplantation
- Forteo (teriparatide)
- Gamifant (emapalumab-lzsg)
- Givlaari (givosiran)
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for CNS Embryonal Tumors and Ependymoma
- Hematopoietic Cell Transplantation for Non-Hodgkin’s Lymphomas
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors (GCT)
- Hip Resurfacing
- Hippotherapy
- Imcivree (setmelanotide)
- Juxtapid (lomitapide)
- Kalydeco (ivacaftor)
- Kisqali and Kisqali Femara Co-Pack (ribociclib and ribociclib/letrozole)
- Lipid Apheresis
- Meniscal Allograft and Other Meniscus Implants
- Nerve Blocks for the Treatment of Headaches or Neuralgia
- Non-Contact Ultrasound Treatment for Wounds
- Non-Invasive Vascular Studies
- Noxafil (Posaconazole)
- Ophthalmic VEGF Inhibitors
- Orgovyx (relugolix)
- Orkambi (lumacaftor/ivacaftor)
- Orladeyo (berotralstat)
- Outpatient Pulmonary Rehabilitation
- Padcev (enfortumab vedotin-ejfv)
- Palforzia (peanut allergen powder)
- Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel
- Plugs for Anal Fistula Repair
- Praluent (alirocumab)
- Prolotherapy
- Quantitative Sensory Testing
- Reduction Mammaplasty for Breast-Related Symptoms
- Repatha (evolocumab)
- Step Therapy
- Symlin (pramlintide)
- Tazverik (tazemetostat)
- Topical Tazarotene
- Transanal Endoscopic Microsurgery (TEM)
- Whole Gland Cryoablation of Prostate Cancer
- Xalkori (crizotinib)
- Xeljanz/Xeljanz XR (tofacitinib)
- Xifaxan (rifaximin)
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
